ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration
Condition(s):Geographic AtrophyLast Updated:March 6, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Geographic AtrophyLast Updated:March 6, 2024Completed
Condition(s):Geographic AtrophyLast Updated:March 1, 2023Completed
Condition(s):Geographic Atrophy; Age-related Macular DegenerationLast Updated:September 18, 2019Completed
Condition(s):Geographic AtrophyLast Updated:October 6, 2020Completed
Condition(s):Geographic Atrophy; Age Related Macular DegenerationLast Updated:August 13, 2019Withdrawn
Condition(s):Age-Related Macular Degeneration; Geographic Atrophy; Reticular PseudodrusenLast Updated:February 17, 2020Completed
Condition(s):Age Related Macular DegenerationLast Updated:December 14, 2020Unknown status
Condition(s):Age Related Macular Degeneration; Geographic AtrophyLast Updated:January 20, 2014Completed
Condition(s):Geographic Atrophy; Age-Related Macular DegenerationLast Updated:July 3, 2014Terminated
Condition(s):Geographic AtrophyLast Updated:September 11, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.